Applied Therapeutics's market cap is currently $65.76M. The company's EPS TTM is $-1.321; its P/E ratio is ―; Applied Therapeutics is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 9.99M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 9.64M	$ -441.00K	$ -415.00K	$ -380.00K	$ -23.00K
Operating Income	$ -64.53M	$ -82.95M	$ -105.62M	$ -94.47M	$ -45.58M
EBITDA	$ -64.53M	$ -82.07M	$ -105.17M	$ -94.47M	$ -45.58M
Net Income	$ -119.76M	$ -81.69M	$ -104.61M	$ -93.02M	$ -45.40M
Balance Sheet
Cash & Short-Term Investments	$ 49.90M	$ 30.58M	$ 80.82M	$ 96.83M	$ 38.85M
Total Assets	$ 54.83M	$ 38.36M	$ 89.89M	$ 104.51M	$ 48.39M
Total Debt	$ 777.00K	$ 891.00K	$ 1.33M	$ 1.74M	$ 2.04M
Net Debt	$ -49.12M	$ -15.77M	$ -52.55M	$ -55.73M	$ -16.81M
Total Liabilities	$ 71.98M	$ 34.30M	$ 27.35M	$ 22.57M	$ 15.78M
Stockholders' Equity	$ -17.15M	$ 4.06M	$ 62.54M	$ 81.94M	$ 32.61M
Cash Flow
Free Cash Flow	$ -55.17M	$ -78.09M	$ -90.73M	$ -78.21M	$ -36.31M
Operating Cash Flow	$ -55.17M	$ -78.09M	$ -90.73M	$ -78.21M	$ -36.31M
Investing Cash Flow	$ 13.87M	$ 13.17M	$ 12.43M	$ -19.47M	$ -20.01M
Financing Cash Flow	$ 74.54M	$ 27.69M	$ 74.72M	$ 136.29M	$ 56.41M

Currency in USD

Applied Therapeutics Earnings and Revenue History

Income Statement >

Applied Therapeutics Debt to Assets

Balance Sheet >

Applied Therapeutics Cash Flow

Cash Flow >

Applied Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing